Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.

Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9

Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.

Cooke GS. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 346 - 365

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers

Pukrittayakamee S. et al, (2024), eLife, 12

Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

Wongnak P. et al, (2024)

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

Luvira V. et al, (2024), BMC Infectious Diseases, 24

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)

Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325

Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.

Janekrongtham C. et al, (2023), BMJ open, 13

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)

Schilling WHK. et al, (2023), eLife, 12

Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry.

Chirapongsathorn S. et al, (2023), Journal of clinical and translational hepatology, 11, 88 - 96

Severity of COVID-19 in Patients with Diarrhoea: A Systematic Review and Meta-Analysis.

Dhakal S. et al, (2023), Tropical medicine and infectious disease, 8

Regional Differences in Admissions and Treatment Outcomes for Hepatocellular Carcinoma Patients in Thailand.

Kitiyakara T. et al, (2022), Asian Pacific journal of cancer prevention : APJCP, 23, 3701 - 3715

Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand.

Srikirin P. et al, (2022), The American journal of tropical medicine and hygiene

Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.

Yuen M-F. et al, (2022), Hepatology communications

Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B.

Limothai U. et al, (2022), Asian Pacific journal of allergy and immunology, 40, 87 - 93

Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study.

Chirapongsathorn S. et al, (2022), BMC health services research, 22

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.

Sriboonvorakul N. et al, (2021), Journal of clinical medicine, 10

Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry

Sriboonvorakul N. et al, (2021), International Health, 13, 367 - 373

Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand

Luangasanatip N. et al, (2021), Vaccine, 39, 1402 - 1414

Load More

Include forthcoming?